Kadmon Pharmaceuticals is a Pharmaceuticals company based at 450 E 29th St, New York City, New York 10016, US founded in Jan. 1, 2010, midnight.
View Top Employees from Kadmon PharmaceuticalsWebsite | http://www.kadmon.com |
Ticker | KDMN |
Revenue | $5 million |
Funding | $412.2 million |
Employees | 3 (3 on RocketReach) |
Founded | 2010 |
Address | 450 E 29th St, New York City, New York 10016, US |
Phone | (833) 900-5366 |
Fax | (646) 666-7978 |
Industry | Pharmaceuticals, Healthcare |
Web Rank | 7 Million |
Keywords | Kadmon International Ltd, Kadmon, Kadmon Holdings, Harlan Waksal, Kadmon Holdings Inc |
Competitors | Aptinyx Inc., GlycoMimetics, Insmed Incorporated, Sorrento Therapeutics, Inc., Vanda Pharmaceuticals |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies |
Looking for a particular Kadmon Pharmaceuticals employee's phone or email?
The Kadmon Pharmaceuticals annual revenue was $5 million in 2024.
Faical Miyara is the Head of Global Partnering Oncology of Kadmon Pharmaceuticals.
3 people are employed at Kadmon Pharmaceuticals.
Kadmon Pharmaceuticals is based in New York City, New York.
The NAICS codes for Kadmon Pharmaceuticals are [54, 32541, 3254, 325, 32, 541].
The SIC codes for Kadmon Pharmaceuticals are [283, 28].